5 March 2020

Oncode Quarterly Magazine - March 2020

Welcome to the March edition of our quarterly magazine. This edition contains interviews with Oncode researchers, scientific highlights and much more.

Elize Brolsma

In this edition, Rudy Dekeyser – partner at LSP and one of the key driving forces behind the foundation of Oncode Institute - and Oncode Investigator Jeroen de Ridder reflect on Oncode’s proactive valorization approach. Next, you get to know Oncode Investigator Carl Figdor (Radboudumc) who explains his love for science and is developing cutting edge technologies in cell therapy. Our cutting edge science is also featured in this edition. We visited the lab of Oncode Investigator Marvin Tanenbaum who takes us on a journey about the regulation of gene expression.

All this and much more is just a single click away. Feel free to share our stories and let us know what you think: we like to hear from you.

Click here to open the magazine

Other News

Oncode Coverbeeld Q2 2021
Oncode Digital Magazine - April 2021
Welcome to the April edition of our digital magazine! Discover the latest interviews, science stories, latest updates and much more.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Lude and Michiel
Oncode Investigators Michiel Vermeulen and Lude Franke receive Vici grant
Oncode is proud to announce that Oncode Investigators Michiel Vermeulen (Radboudumc) and Lude Franke (UMCG) will both receive the Vici grant of 1.5 million euros from the Dutch Research Council (NWO).
PeterThijssen
Ecto org KRT14
First patient-derived organoid model for cervical cancer
Researchers from the group of Oncode Investigator Hans Clevers (Hubrecht Institute) developed the first patient-derived organoid model for cervical cancer. They also modelled the healthy human cervix using organoids. In close collaboration with the UMC Utrecht, Princess Máxima Center for pediatric oncology and the Netherlands Cancer Institute, the researchers used the organoid-based platform to study sexually transmitted infections for a herpes virus. The model can potentially also be used to study the human papillomavirus (HPV), which is one of the main causes of cervical cancer.
Bianca-OliviaNita